MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Bradykinesia"

  • 2024 International Congress

    Motor Onset of Parkinson’s disease: the proximal limbs are first

    MA. Ruiz Yanzi, M. Matarazzo, T. Jiménez-Castellanos, JA. Pineda-Pardo, MHG. Monje, A. Sánchez-Ferro, C. Gasca-Salas, R. Martínez-Fernández, JA. Obeso (Madrid, Spain)

    Objective: To determine if proximal body parts are more affected than distal body parts at the clinical onset of Parkinson’s disease (PD). Background: Motor features…
  • 2024 International Congress

    Young-onset Parkinson’s disease in a female with pathogenic deletion of the PRRT2 gene

    M. Chen, M. Christie (Houston, USA)

    Objective: To report a novel case of young-onset Parksinon’s disease (YOPD) associated with a pathogenic deletion of the proline-rich transmembrane protein 2 gene (PRRT2). Background:…
  • 2024 International Congress

    Adding Parkinsonism to the Phenotypic Spectrum of FIG4-related diseases

    K. Pyle, G. Pawar, J. Frey (Morgantown, USA)

    Objective: To describe a phenotypic variant of FIG4-related diseases resulting in parkinsonism. Background: The FIG4 gene codes for P1(3,5)P2 phosphatase that plays an important role…
  • 2024 International Congress

    Deep brain stimulation-evoked potentials as an avenue to optimize stimulation outcomes in Parkinson’s disease

    B. Bahners, L. Goede, G. Meyer, L. Poser, L. Hart, A. Kühn, A. Horn (Boston, USA)

    Objective: Use deep brain stimulation (DBS)-evoked potentials recorded using dry-EEG electrodes to estimate stimulation outcome. Background: Subthalamic DBS effectively alleviates motor symptoms in Parkinson’s disease.…
  • 2024 International Congress

    Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.

    C. Holgado, M. Wilken, G. Lopez, M. Merello (Buenos Aires, Argentina)

    Objective: To develop  a bedside  quantitative test for evaluating motor affectation  in patients with Parkinson's Disease. Background: The MDS-UPDRS part III is still the most…
  • 2024 International Congress

    Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals

    G. Paparella, M. de Riggi, A. Cannavacciuolo, D. Costa, D. Birreci, M. Passaretti, L. Angelini, A. Berardelli, M. Bologna (rome, Italy)

    Objective: To evaluate, through kinematic analysis, the major phenomenological features of bradykinesia, with a specific focus on their combination, in a relatively large sample of…
  • 2024 International Congress

    Abstract: Trends in Movement Disorders related death in the United States from 1999 to 2020

    A. Khalid, L. Munir, A. Chaudhary, M. Ammar-Ur-Rahman, A. Alabedi (Lahore, Pakistan)

    Objective: We aimed to analyze the mortality and prevalence of movement disorders in the United States from 1999 to 2020 to compare disparities among various…
  • 2024 International Congress

    Levels of ferritinemia in Parkinson’s disease patients who underwent Covid-19

    B. Amonov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: In the scientific literature, there is information about the…
  • 2024 International Congress

    MOVE-PD: Mapping the Correlation of Sedentary behavior with Motor Symptoms in Parkinson’s Disease

    J. Frederiksen, TH. Thomsen, B. Biering- Sørensen, U. Dalgas, M. Langeskov-Christensen (Glostrup, Denmark)

    Objective: Mapping the correlation between sedentary behavior (SB) and Parkinsons (PD) specific motor symptoms, measured on objective data from wearables. Background: People with Parkinson's (Pwp)…
  • 2024 International Congress

    The Spatiotemporal Characteristics of Floor Sitting Rising in Parkinson’s Disease (PD)

    J. Alomar, D. Wani, T. Yu, S. Leung, L. Romero, S. El-Feky, J. Wong, K. Pu, L. Quinn (New York City, USA)

    Objective: To develop a method to characterize Floor Sitting Rising (FSR) in people with Parkinson disease (PwP). Background: Transitioning to the floor to a seated…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley